Company Profile

Stheno Corporation
Profile last edited on: 9/9/10      CAGE: 4CT01      UEI:

Business Identifier: Magneto-Optical Enantiomeric Detection (MOPED) for real-time, non-contact analysis of chiral pharmaceuticals
Year Founded
2003
First Award
2003
Latest Award
2008
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

311 Ferst Drive NW Suite L1362
Atlanta, GA 30332
   (404) 526-6193
   N/A
   www.sthenocorp.com
Location: Single
Congr. District: 05
County: Fulton

Public Profile

Stheno Corporation develops chiral analysis instruments to check chiral purity in agrochemicals, flavor and fragrance ingredients, and pharmaceuticals. Its product 1000-OR, which is based on magneto-optical enantiomeric detection technology is used in various applications, such as achiral stationary phase HPLC separations monitoring for optical activity, chiral stationary phase HPLC separations monitoring for chiral signature, gradient method HPLC separation monitoring, online process monitoring, HPLC/MS chiral signature determination, and species identification for analytes lacking accessible chromophore.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
1-4
Revenue Range
Less than .5M
VC funded?
Yes
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2008 2 NIH $865,172
Project Title: Differential Optical Rotation for Chiral Analysis
2003 1 NSF $94,103
Project Title: Online Chiral Detector for Industrial Bioprocessing

Key People / Management

  William A Edens -- CEO

  Phillip R Gibbs -- CSO

  Peter Petrecca -- VP, Operations

Company News

There are no news available.